Showing 1 - 10 of 13
version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient … coinsurance. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales …
Persistent link: https://www.econbiz.de/10009691207
Persistent link: https://www.econbiz.de/10009762378
Persistent link: https://www.econbiz.de/10008655517
version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient … coinsurance. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales …
Persistent link: https://www.econbiz.de/10013088216
version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient … generics and their market shares. In terms of policy implications, our results suggest that pharmacy incentives are crucial for …
Persistent link: https://www.econbiz.de/10013139185
Therapeutic reference pricing (TRP) of pharmaceuticals is widely thought to steer drug innovation incentives away from …, TRP reduces innovating firms' incentives for therapeutic differentiation and leads to entry of drugs that are less … innovation incentives. On the other hand, TRP leads to lower health benefits unless incentives for therapeutic differentiation …
Persistent link: https://www.econbiz.de/10014243453
Persistent link: https://www.econbiz.de/10003379831
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry...
Persistent link: https://www.econbiz.de/10003393611
Persistent link: https://www.econbiz.de/10014426057
Persistent link: https://www.econbiz.de/10014481072